1. Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?

   Knapen, D. G., de Groot, D. J. A., Kwee, T. C., Meijne, E. I. M., Fehrmann, R. S. N. & de Vries, E. G. E., Jul-2020, In : CANCER TREATMENT REVIEWS. 87, 4 p., 102027.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial

   Dutch Pancreatic Canc Grp, Mackay, T. M., Smits, F. J., Latenstein, A. E. J., Bogte, A., Bonsing, B. A., Bos, H., Bosscha, K., Brosens, L. A. A., Hol, L., Busch, O. R. C., Creemers, G. J., Curvers, W. L., den Dulk, M., van Dieren, S., van Driel, L. M. J. W., Festen, S., van Geenen, E. J. M., van der Geest, L. G., de Groot, D. J. A., de Groot, J. W. B., Haj Mohammad, N., Haberkorn, B. C. M., Haver, J. T., van der Harst, E., Hemmink, G. J. M., de Hingh, I. H., Hoge, C., Homs, M. Y. V., van Huijgevoort, N. C., Jacobs, M. A. J. M., Kerver, E. D., Liem, M. S. L., Los, M., Lubbinge, H., Luelmo, S. A. C., de Meijer, V. E., Mekenkamp, L., Molenaar, I. Q., van Oijen, M. G. H., Patijn, G. A., Quispel, R., van Rijssen, L. B., Roemkens, T. E. H., van Santvoort, H. C., Schreinemakers, J. M. J., Schut, H., Seerden, T., Stommel, M. W. J., Verheij, J., Wilmink, J. W., Van Laarhoven, H. W. M. & Besselink, M. G., 16-Apr-2020, In : TRIALS. 21, 1, 18 p., 334.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

   Boonstra, P. A., Wind, T. T., van Kruchten, M., Schuuring, E., Hospers, G. A. P., van der Wekken, A. J., de Groot, D-J., Schröder, C. P., Fehrmann, R. S. N. & Reyners, A. K. L., 4-May-2020, In : Cancer and metastasis reviews. 15 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm

   Suurs, F. V., Lorenczewski, G., Stienen, S., Friedrich, M., de Vries, E. G. E., De Groot, D. J. A. & Lub-de Hooge, M. N., 13-Apr-2020, In : Journal of Nuclear Medicine. 41 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

   Collaborative investigators, van der Valk, M. J. M., Marijnen, C. A. M., van Etten, B., Dijkstra, E. A., Hilling, D. E., Kranenbarg, E. M-K., Putter, H., Roodvoets, A. G. H., Bahadoer, R. R., Fokstuen, T., Ten Tije, A. J., Capdevila, J., Hendriks, M. P., Edhemovic, I., Cervantes, A. M. R., de Groot, D. J. A., Nilsson, P. J., Glimelius, B., van de Velde, C. J. H. & Hospers, G. A. P., Jun-2020, In : Radiotherapy and Oncology. 147, p. 75-83 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (35) »